Facial ageing treatment can be broadly divided into three stages: preventative, early corrective, and structural corrective. These stages reflect how advanced the underlying changes are in the skin, fat, and structural support of the face. Most people fall into more than one category depending on the facial region, the under eyes, midface, and jawline can each be at different stages simultaneously. Understanding which stage best describes your face determines the most appropriate treatment approach, timing, and goals.
Why Stage Matters More Than Age
One of the most persistent misconceptions about cosmetic aesthetics is that it is primarily age determined, that there is a correct age to start, a correct age to change approach, and a universal progression that applies to everyone. In practice, the most relevant determining factor is not chronological age but anatomical stage: which changes have actually occurred in the face, how far they have progressed, and what the underlying structural situation looks like.
The concept of aesthetic staging, preventative, early corrective, and structural corrective, provides a more clinically useful framework than age because it describes what is actually happening in the face rather than how many years a person has lived. Two people of the same age can be in entirely different stages. A 35-year old with significant volume loss and early structural changes may benefit from an early corrective approach that would not be appropriate for a 45-year old whose face has retained excellent structural support and is better served by a preventative strategy.
Understanding your stage, not your age, is the starting point for any informed treatment conversation.
Stage One. Preventative Aesthetics
Preventative aesthetics refers to treatment aimed at maintaining the existing facial structure, slowing the rate of visible change, and preserving the anatomical integrity of the face before significant volume or structural loss has occurred. It is not about doing nothing, it is about doing the right things at the right time to extend the period during which the face retains its natural balance.
In the context of cosmetic injectables, preventative treatment typically involves muscle relaxant injections to reduce the cumulative effect of repeated facial expressions on the overlying skin. Over time, repeated contraction of the same muscle groups, particularly the forehead, glabellar, and orbital regions, creates persistent surface lines that deepen progressively. Reducing the intensity of these contractions before deep static lines form reduces the rate at which they develop.
Preventative aesthetics may also include early, conservative filler approaches to maintain structural volume before significant loss has occurred. The goals are modest: maintaining proportion, supporting existing structure, and avoiding the changes that require more substantial corrective intervention later.
People in a preventative stage typically present with minimal visible structural change, good facial volume, and skin quality changes as the primary concern. They are often in their late twenties to late thirties, though this varies substantially by individual.
Stage Two. Early Corrective Aesthetics
Early corrective aesthetics refers to treatment designed to address changes that have already become visible but have not yet progressed to the point where significant structural support has been lost. The goal is to restore early changes before they compound and become more difficult to address effectively.
Common presentations in the early corrective stage include noticeable under-eye hollowing or shadowing, early midface flattening, reduction of cheek definition, early nasolabial deepening, and the beginning of jawline softening. The structural support of the face is largely intact; the visible changes reflect volume loss and early fat pad repositioning rather than fundamental structural failure.
This stage is often when people become most motivated to seek treatment, the changes are visible enough to be noticeable in photographs and mirrors, but early enough that restoration of close to original proportions is achievable. Treatment at this stage tends to require less volume and less structural scaffolding than treatment at a later stage because the fundamental architecture is still in place.
The early corrective stage typically spans the late thirties to the early fifties, though again, individual variation is considerable. Some people enter this stage earlier due to genetic factors, lifestyle influences, or facial structure; others remain in a preventative or early corrective position well into their fifties.
Stage Three. Structural Corrective Aesthetics
Structural corrective aesthetics refers to treatment required when significant structural changes have occurred, when ligament laxity, bone remodelling, and substantial fat pad descent have altered the fundamental architecture of the face. This stage requires a more comprehensive approach because the changes being addressed are not simply volumetric but structural.
Common presentations in the structural corrective stage include established jowling, significant midface descent, deep nasolabial and melomental folds, jawline irregularity, and marked periorbital hollowing. The face in this stage has undergone changes that cannot be fully addressed with a minimal approach; a more considered treatment plan addressing multiple zones and multiple layers is typically required.
This does not mean that all structural corrective patients require extensive treatment. The principle of conservative dosing and gradual improvement over time applies at every stage. But the realistic goals and the treatment volumes required at this stage differ meaningfully from those appropriate at earlier stages, which is why a treatment plan designed for a Stage 2 patient is not simply scaled up for a Stage 3 patient; it must be redesigned from scratch based on the actual structural situation.
Stage 3 presentations are most commonly seen in the fifties and beyond, though earlier presentation is possible in individuals with certain genetic predispositions, significant sun damage history, or pronounced bone loss.
Why Age Does Not Define Your Stage
The relationship between chronological age and anatomical stage is real but loose. Age is one of many factors that influence the rate and pattern of facial ageing, and it cannot serve as a reliable proxy for stage.
Genetic factors have a significant influence on when and how the face ages. Some family lines maintain facial volume and structural support well into the fifties; others show pronounced structural changes by the late thirties. Sun exposure history, particularly cumulative UV exposure in early adulthood, accelerates skin layer ageing independently of structural changes. Lifestyle factors including smoking history, body weight fluctuations, and hormonal transitions (particularly around menopause, which is associated with accelerated facial volume loss) all influence the relationship between age and stage.
For these reasons, a 40-year old presenting with a structurally intact face, good volume, and only early skin quality changes may be in Stage 1 or early Stage 2, while a 40-year old with significant volume loss, early jowling, and deep nasolabial folds may be solidly in Stage 2 or approaching Stage 3. Age provides context; it does not determine stage.
Why Most Faces Are in Multiple Stages Simultaneously
The staging framework becomes more complex when applied to real faces because different facial zones age at different rates. The eyes and periorbital region often show Stage 2 changes while the jawline remains in Stage 1. The midface may be at Stage 2 while the temples, which often hollow early due to temporal muscle reduction, are at Stage 2 or 3. The lower face may remain structurally intact while the under eyes and midface have undergone significant volume changes.
This multi zone, multi stage reality is why a whole-face assessment is more informative than a zone by zone evaluation. The relative contribution of each zone to the overall presentation, and the staging of each zone independently, determines which aspects of treatment are most relevant and most time sensitive.
Understanding that you may be simultaneously in Stage 1 for some areas and Stage 2 for others is a more accurate framework than attempting to classify your entire face as a single stage. Most adults in their late thirties and forties will find themselves in this mixed stage position.
The Risk of Stage Mismatch. Over or Under-Treatment
Applying a Stage 3 treatment approach to a Stage 1 patient, using substantial volumes, addressing multiple zones, and treating as though significant structural loss has occurred, can produce disproportionate results that do not improve on the natural face. Over-treatment at an early stage can alter the natural proportions of a face that did not require significant correction.
Conversely, applying a Stage 1 preventative approach to a Stage 3 patient, using conservative volumes and minimal zones, can produce inadequate change relative to the degree of structural deficit, leaving significant correctable changes unaddressed.
Stage mismatch is one of the most common causes of unsatisfying aesthetic outcomes, not technical failure, but a fundamental mismatch between the treatment approach and the actual anatomical situation. A proper consultation and assessment process, which evaluates the stage of ageing in each facial zone independently, is the primary safeguard against this.
Preventative vs Corrective. What the Difference Means for Timing
One of the practical implications of stage awareness is that it informs timing. Preventative treatment, by definition, is most effective when begun before the changes it is preventing have occurred or become established. Waiting until significant lines or volume loss are present to begin preventative treatment means that the preventative window has partially passed, the approach must shift toward early corrective rather than purely preventative.
This does not mean that everyone should begin treatment as early as possible. Many people in their twenties have no indication for any cosmetic injectable treatment, and beginning treatment without indication serves no useful anatomical purpose. The appropriate question is not when to start but what stage the face is actually in and what that stage suggests about the appropriate approach.
The AHPRA guidelines for cosmetic injectables reinforce this point through their requirement for a standalone consultation. The consultation process is precisely the mechanism for determining stage and aligning treatment goals with the actual anatomical presentation, rather than proceeding on the basis of age or general trend.
long term Thinking and Stage-Aware Treatment Planning
A stage aware approach to treatment planning looks not just at the current presentation but at the likely trajectory of ageing and how treatment choices at the current stage will interact with changes at future stages. This is consistent with a long term planning philosophy, one of the principles at Core Aesthetics that distinguishes gradual, anatomy led treatment planning from reactive, symptom led treatment.
For example, a patient in Stage 1 who is considering preventative muscle relaxant treatment benefits from a plan that considers how the brow dynamics and upper face architecture will evolve over the coming years, so that treatment in the forehead region today does not inadvertently compromise brow position or upper face expression as the underlying anatomy changes.
A patient in Stage 2 who is beginning filler treatment in the midface benefits from a plan that considers the likely progression of lower face structural changes over the coming years, so that the volume plan today is sequenced in a way that supports the whole face rather than optimising a single zone that will later shift out of proportion as adjacent areas change.
This kind of longitudinal thinking, treating the face as an evolving anatomical system rather than a collection of discrete problems, is what distinguishes stage aware aesthetic planning from single appointment symptom management.
Common Misconceptions About Aesthetic Stages
Several common misconceptions about aesthetic staging are worth addressing. The first is that preventative treatment is only appropriate for young people. Stage 1 presentations can occur at any age; whether preventative treatment is indicated depends on the anatomy, not the age.
The second misconception is that all cosmetic injectable treatment is corrective. A substantial proportion of cosmetic injectable treatment, particularly muscle relaxant injections for expression lines in younger adults, is genuinely preventative in intent and function.
The third misconception is that once in a corrective stage, more treatment is always better. The principle of proportionality applies at every stage. Stage 3 patients benefit from a considered, gradual approach that improves facial balance without overcorrection, just as Stage 1 patients benefit from conservative treatment that respects the existing anatomy.
The fourth misconception is that stages are permanent categories. Facial ageing is progressive; a person who is in Stage 1 today will move toward Stage 2 over time. Stage awareness is therefore a dynamic assessment rather than a fixed classification, and the treatment approach appropriate for a patient should be reviewed over time as the anatomy evolves.
About This Information
This page provides educational information about the concept of aesthetic staging as applied to facial ageing. It is not a clinical assessment and is not a substitute for a consultation with a registered health practitioner. The stages described here are frameworks for understanding different treatment philosophies and are not diagnostic categories.
All information on this page complies with AHPRA guidelines for registered health practitioners performing nonsurgical cosmetic procedures and with the TGA Therapeutic Goods Advertising Code. No product or brand names are referenced. No treatment outcomes are promised or implied.
Is this for you?
This may not be for you if
- Those seeking a specific treatment recommendation without a consultation
- Individuals with no interest in understanding the anatomical basis of treatment decisions
Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.
Frequently asked questions
What is preventative aesthetics?
Preventative aesthetics refers to treatment aimed at maintaining existing facial structure and slowing the progression of visible ageing before significant volume or structural loss has occurred. It typically involves conservative muscle relaxant injections to reduce expression driven line formation and, in some cases, early filler approaches to preserve structural volume.
When should I start preventative cosmetic injectables?
There is no universal age at which preventative treatment is appropriate. The indication is based on anatomy, specifically, whether expression driven lines are beginning to form between muscle contractions, indicating that preventative treatment would reduce their progression. A consultation is the appropriate way to determine whether this is relevant for a specific individual.
Can you be in multiple aesthetic stages at once?
Yes. Different facial zones age at different rates, and most adults in their late thirties and forties will find that some areas are at an earlier stage while others have progressed further. The under eyes and midface often show Stage 2 changes while the jawline remains in Stage 1, for example.
Is early corrective treatment better than waiting?
Addressing early corrective changes before they progress to a more advanced stage generally requires less intervention to achieve similar goals. However, whether treatment is appropriate depends on the individual anatomy, the degree of visible change, and the patient’s own assessment of whether the changes warrant intervention.
What is the difference between Stage 2 and Stage 3 treatment?
Stage 2 treatment typically addresses early volume loss and repositioning in the context of largely intact structural support. Stage 3 treatment addresses more established structural changes, often requiring a more comprehensive approach across multiple zones. The goals, volumes, and treatment sequence appropriate for each stage differ substantially.
Does AHPRA affect what stage of treatment I can have?
AHPRA guidelines affect how treatment is delivered rather than which stage is appropriate. The requirement for a mandatory standalone consultation before treatment applies to all patients regardless of stage. The consultation process is designed to ensure that treatment decisions are based on an adequate assessment of the individual anatomy.
Why does the same treatment sometimes look different on different people?
Because the same treatment applied to different anatomical stages, different facial structures, and different underlying volumes produces different results. Treatment that is proportionate for a Stage 2 patient may be disproportionate for a Stage 1 patient and inadequate for a Stage 3 patient, which is why stage assessment is the foundation of appropriate treatment planning.
What does conservative dosing mean in cosmetic injectables?
Conservative dosing refers to using the minimum effective amount of injectable product to achieve a balanced, proportionate improvement. It is a principle that applies at all stages of ageing and reflects the understanding that the goal of treatment is proportion, not maximum volume or maximum muscle relaxation.